InvestorsHub Logo
Followers 0
Posts 154
Boards Moderated 0
Alias Born 09/04/2009

Re: Ecomike post# 36

Wednesday, 12/02/2009 5:41:30 PM

Wednesday, December 02, 2009 5:41:30 PM

Post# of 1435
I don't think they will restrict the shares. The new members of Ariston will have a nice payday within a year, for handing manhattan their development products. Having the shares non-restricted, I am sure is part of the deal. I just received the email from investor relations, all proposals did pass at the shareholder meeting on 11-30-09. All 5. They have increased shares available, increased stock options by 7 million shares, elected all nominated directors. Here is the email, we shall know soon.

Hello Mr. Phillips:



As stated on page 4 of the proxy statement the detailed results of the voting at the Annual Meeting are to be published in the annual report for the year ending December 31, 2009. Until then, I am not permitted to release the detailed information outside the shareholder meeting. I can tell you that all the proposals did pass, and all the nominated directors were elected.



I hope this information answers your question. Please feel free to contact me if I can be of further assistance.



Best regards,

Michelle Y. Carroll

Director, Strategic Development & Investor Relations

Manhattan Pharmaceuticals, Inc.

212.492.8747 direct

mcarroll@manhattanpharma.com
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TGTX News